Interest in the anti-inflammatory effects of Ligustrum vulgare L., which has been used traditionally in China and Japan prompted us to determine antiinflammatory effects of the plant's compounds in leukocytes. The leaves of L. vulgare were used to prepare a decoction which was successively extracted with organic solvents (dichloromethane (DCM), n-butanol, ethyl acetate) using liquid-liquid partition. Extracts were tested for inhibition of LTB 4 , resp. PGE 2 biosynthesis. Each extract was evaluated for its in vitro cyclooxygenase-1/2 (COX-1/2) inhibitory activity using assays with purified COX-1 and COX-2 enzymes, as well as for their LTB 4 formation inhibitory activity using an assay with activated human neutrophil granulocytes. All extracts reported inhibitory actions against COXs in comparison with the synthetic inhibitors NS-398 (IC 50 = 2.6 µM) and indomethacin (IC 50 = 0.9 µM). The dichloromethane extract of privet leaves showed a considerable inhibitory effect against COX-1 and COX-2 enzyme activity. The DCM extract revealed 2.7 times higher inhibitory activity against LTB 4 formation in comparison with the known specific LT inhibitor zileuton (IC 50 = 5.0 µM). Additionally, oleuropein and echinacoside were detected by HPLC-DAD and LC-MS in the Ligustrum vulgare leaves. Both compounds exhibited weak inhibitory activity on cyclooxygenases and leukotriene formation.
Leaves of various Ligustrum species have been widely used as medicinal tea or a vulnerary drug in folk medicine in European, Chinese, and Japanese communities. Ligustrum robustum (Roxb.) Blume, L. pedunculare Rehd., L. purpurascens Y. C. Yang, and L. henryi Hemsl. are representative Ligustrum species for producing the Chinese Ku-Ding-Cha, a traditional medicinal bitter spike-leaf beverage like 'mate'. Ku-Ding-Cha has been recognized as treatment for sore throat, an aid to weight loss and is used to prevent cardiovascular and inflammatory diseases [1] . The usage of Ligustrum sp. in prevention and therapy of various inflammatory disorders (in mouth, throat, wounds, rheumatic processes etc.) has been correlated to several isolated active constituents [2] . First, references about medicinal use of common privet were already described by Dioscorides (1 st century BC) and its biological effects are caused by glycosides, namely flavonoids and phenylpropanoids, phenylethanoid derivatives and terpenoids (mainly secoiridoids). Iridoid glucosides are present in the form of esters and glycosides of tyrosol (p-hydroxyphenyl-ethanol) and of closely related dopaol (3,4-dihydroxyphenyl-ethanol) . Secoiridoids and other compounds of L. vulgare leaves were effective in clinical trials and exhibited a wide spectrum of pharmacological properties [3] . Coumarins, lignan glucosides and other compounds are present in lower amounts.
Plants of the genus Ligustrum are used in prevention and healing of hepatitis and chronic bronchitis. This is due to their different triterpenoid contents and its liver-protecting, antiviral and antimutagenic activities [4] . Methanol extracts of Ligustrum species showed analgesic and anti-inflammatory properties in the acetic acid-induced writhing test, the formalin-induced licking test and the carrageenan-induced paw edema test [5] . An ethanolic extract of privet leaves exhibited weak activity against Gram-positive bacteria [6] and cytotoxic activity against HeLa cells [7] . The ethyl acetate extract from L. vulgare leaves significantly inhibited the angiotensin converting enzymes and neutral endopeptidase [8] .
Flavonoid aglycones (luteolin, kaempferol and quercetin) detected in the butanol extract of privet leaves are compounds with potential anti-cancer activity [9,10c] .
The phenolic compounds of a water infusion of privet showed radical -scavenging activities in the DPPH assay, and antioxidant activity of isolated phenolics was described in various other assays [10a,10b,14] . Antimutagenic activity of phenolics from water infusions of leaves was shown against ofloxacin. Benzyl ether phomosine I from the endophytic fungus Phomopsis sp., which was isolated following surface sterilization from L. vulgare, was antifungal as well as antibacterial [11] .
The most abundant secoiridoid compound of privet leaves, oleuropein, showed anti-inflammatory activity by inhibition of lipoxygenase and leukotrienes B 4 (LTB 4 ) production [12] . Oleuropein has also the ability to scavenge free radicals and protect other dietary antioxidants such as vitamin C and α-tocopherol from degradation in the intestine [13] . Other studies showed that phenolic components (hydroxytyrosol > oleuropein > caffeic acid > tyrosol) exert selective inhibitory activity against the 5-LO (leukotriene) pathway of arachidonate metabolism in activated leukocytes without affecting the cyclooxygenase pathway. It was found that most phenolics are typical antioxidants, which are able to inhibit both animal and plant lipoxygenase enzymes [12, 14] .
Cyclooxygenases and 5-LOX are key enzymes of arachidonate metabolism which lead to the production of important mediators of inflammation [15] . Leukotrienes (LT) are lipid inflammatory mediators derived from phospholipase-released arachidonic acid (AA) and synthesized by 5-lipoxygenase (5-LO) [16] . They are involved in numerous homeostatic biological functions and inflammation and have pivotal roles in the pathophysiology of various diseases such as asthma, psoriasis, inflammatory bowel disease and chronic inflammatory states (rheumatoid arthritis).
Besides their physiological activities, prostaglandins are important mediators of pain perception and inflammatory processes [16a,17] . Therefore, the inhibition of LT and prostaglandin (PG) production by blocking the activities of 5-lipoxygenase, or 5-lipoxygenase and cyclooxygenase-2, leads to decrease of many inflammatory processes in human tissues, influences nonspecific defense mechanisms and activates an immune response.
Caffeic acid derivatives present in L. vulgare leaves, such as echinacoside (ECH), are known to be not only good antioxidants, but are also functionally linked to anti-inflammatory and wound healing properties of Echinacea, and were shown to inhibit lipid peroxidation involved in the development of inflammation. ECH, as a typical phenylethanoid glycoside, has immunomodulatory activity and is capable of stimulating mainly the non-specific cellular immune system. It also exhibited neuroprotective and anti-apoptotic effects in vitro [18] . We assumed that oleuropein and echinacoside could contribute to the inflammatory properties of privet leaves. Based on the investigations reviewed we have tested the anti-inflammatory properties of L. vulgare extracts as well as oleuropein and echinacoside and their potency to inhibit leukotriene B 4 (LTB 4 ) formation and COX enzymes isolated from ram seminal vesicles and microsomal preparations.
Effects of extracts of Ligustrum vulgare leaves on formation of eicosanoids:
The anti-inflammatory activities of DCM, EtOAc, n-BuOH and water extracts of L. vulgare leaves and of oleuropein and echinacoside were evaluated by COX-1, COX-2 and LTB 4 formation inhibitory assays (Table 1) .
At a screening concentration of 50 µg/mL, all tested extracts of L. vulgare leaves, as well as oleuropein and echinacoside, showed inhibitory activity against purified PGHS-1 and PGHS-2 enzymes. Both tests were performed under the same test conditions, and both enzymes were obtained from the same species and used in equal amounts. This is the first report on the inhibitory activity of L. vulgare extracts (DCM, EtOAc, n-BuOH) on LTB 4 and PGE 2 formation. Out of all the samples tested towards COX-1, the DCM extract revealed the highest inhibitory effect compared with a positive indomethacin control at 0.9 µM (71.3% of indomethacin inhibition). The EtOAc extract of L. vulgare inhibited the formation of COX-1 products by 56.1% and the n-BuOH extract by 19.3%, while oleuropein and echinacoside analyzed at 50 µM test concentration showed lower inhibitory effect in comparison with the measured value of indomethacin activity (1.7% and 26.2% of indomethacin inhibition, respectively). The water extract of L. vulgare was not active (NA). In the case of the inhibition of PGH-2 production by COX-2, the EtOAc and n-BuOH extracts from L. vulgare leaves (50 µg/mL) showed the highest inhibitory potency in comparison with the positive control NS-398 (2.6 µM) (81.5% and 74.6% activity of NS-398). The DCM extract showed weak activity (34.0% activity of NS-398) in comparison with EtOAc and n-BuOH extracts at the same inhibitory concentration in the COX-2 in vitro assay. Oleuropein and echinacoside showed lower inhibitory effect on COX-2 (68.6%, 62.2%) compared with the positive control, but their activities were higher than in the COX-1 test system. The water extract of L. vulgare inhibited formation of PGHS-2 weakly (1.9%). The n-BuOH extract, oleuropein and echinacoside showed significant inhibitory effects on both PGHS isoforms. The EtOAc extract was significantly effective in the COX-1 inhibition bioassay. In conclusion, all tested samples achieved better inhibitory effects against COX-2 than against COX-1, and all samples reported statistical significance against COX-2, except the EtOAc extract (Figure 1 ). COX-2 inhibitory activities of echinacoside and of the EtOAc extract were almost twice as strong as that of the DCM extract, and had a 3-times higher activity on COX-1 enzyme. Echinacoside and oleuropein exhibited a higher degree of inhibition on COX-2 than on COX-1.
Despite the fact that oleuropein and echinacoside confirmed certain inhibitory activity on PG formation, our experiments revealed only a minor role of these compounds at the used concentration in clarification of the anti-inflammatory activity of L. vulgare extracts.
In our investigation, the inhibition of 5-LOX mediated LTB 4 formation using activated human neutrophil granulocytes was tested. All extracts showed no activity and, therefore, there is no association between privet extracts and leukotriene inhibitory effect. Only lyophilized water infusion of leaves of L. vulgare extracted directly in dichloromethane showed a pronounced inhibitory effect on LTB 4 formation at 50 µg/mL concentration in comparison with the specific LTB 4 inhibitor zileuton (IC 50 = 5.0 µM). In this case, its inhibitory effect was almost 2.7-times higher than the same inhibitory effect of the standard. Zileuton is the only 5-lipoxygenase (5-LOX) inhibitor currently marketed as a treatment for asthma, and is often utilized as a selective tool to evaluate the role of 5-LOX and leukotrienes [19] . The DCM extract exhibited also inhibitory effect towards COX-1 and COX-2 used in PG formation in vitro bioassays. However, all tested extracts of privet leaves did not seem to be responsible for the leukotriene inhibitory activity. Further exploration of this could be helpful in explanation of the herb in Anti-inflammatory effects of Ligustrum vulgare Natural Product Communications Vol. 8 (11) 2013 1511 traditional therapy. In our previous work we observed the inhibitory activity of L. vulgare water extract and of oleuropein and echinacoside on lipoxygenase isolated from the cytosolic fraction of rat lungs. Their biochemical and analytical profiles confirmed that all tested samples competitively inhibit the enzymatic process. Oleuropein was the most effective. For determination of inhibitory activity of the samples against LOX, 8-LOX, 12-LOX and 15-LOX, HPLC conditions were also optimized [20] .
While the majority of extracts did not affect the metabolic integrity of the leukocytes at the doses used, the DCM extract was able to inhibit all used enzymes (5-LOX >COX-1>COX-2). Following the results, which showed no inhibitory effect of the water extract of privet in all three test systems, it is not possible to explain the effectiveness of a tea preparation by these assays.
However, the study contributes to our understanding of the biological characterization of privet leaf extracts and components in connection to the selective inhibitory effects against the 5-LO and COX-1/2 pathways of the arachidonate metabolic cascade. Further investigation of inhibitory activities of the extracts and other compounds at different concentrations are needed. On the basis of the ability to scavenge hydrogen peroxide, the phenolics from privet leaves may have inhibitory potential, if they can bind to the central iron atom in the LOX enzyme, or if they are analogues of substrate and product.
Using higher concentrations of more lipophilic extracts of L. vulgare in experimental in vivo models of inflammation could be the way to determine anti-inflammatory potential and prospective therapeutic value of privet leaves.
Experimental

Plant material and extraction:
The leaves of Ligustrum vulgare L. were harvested at the Dendrobiology Institute of the Slovak Academy of Science, Arboretum Mlyňany, in September 2008 and deposited at the Department of Pharmacognosy and Botany, Comenius University, Bratislava, Slovakia. The leaf material was dried at room temperature (22°C). Water infusion from powdered dried leaves was prepared according to the Czech-Slovak Pharmacopoeia IV [21] (20 g of dried leaves to 200 mL), lyophilised when necessary and stored at 4°C. Lyophilisate (3.0 g) was dissolved and divided successively into dichloromethane (DCM), ethyl acetate (EtOAc) and n-butanol (n-BuOH) fractions. Each extract was filtered and concentrated under reduced pressure using a rotary evaporator. The solvent residues were eliminated under nitrogen and extracts were kept in closed glass beakers. The extraction led to the following yields: DCM 3.0%, EtOAc 3.9%, n-BuOH 15.1%, H 2 O 77.9%.
Preparation of samples for the bioassays:
Each DCM, EtOAc and n-BuOH extract of Ligustrum vulgare leaves was dissolved in absolute ethanol to a concentration of stock solution of 1mg/mL and after appropriate dilution used for in vitro assays. Isolated oleuropein was determined and identified at the Department of Pharmacognosy and Botany in Bratislava and used for determination of inhibitory activity. Echinacoside (powder, purity 94.8%) was purchased from Phytolab (Germany). Both compounds were dissolved in EtOH p.a. at a concentration of 50 µM and used for the experiments.
LT formation inhibitory bioassay:
The bioassay used for LTB 4 formation was performed with freshly isolated activated neutrophil granulocytes in 96-well-plate format, as described previously by Adams et al. [16a] and partially modified by Knödler et al. [22] . After isolation of neutrophils from human blood, determination of cell concentration and incubation of the cellular particles for separation of free LTB 4 on 96-microtiter plate, the samples were applied to a competitive Leukotriene B 4 EIA kit (Cayman Chemical, Ann Arbor, USA). The absorbance of produced LTB 4 was quantified by a photometric Tecan RAIN BOW ELISA plate reader at 405 nm. Results were processed using EasyWin Fitting 4.0a. The amount of produced LTB 4 is inversely proportional to the inhibitory activity of the samples. Final concentration of absolute ethanol in control wells was used for expression of inhibition of leukotriene biosynthesis in a blank value and negative control. All samples were tested on two different days, each time in duplicate. Results are presented as means ± SD (MS Office Excel) of the measurements in relation to control values. Zileuton (Sequoia Research Products Ltd., Oxford, UK) was dissolved in EtOH p.a. (10 µM) and used as a positive control for in vitro assays, as described in the literature [16a] . The concentration of extracts in the test solution was 50 µg/mL.
Assays for COX-1 and COX-2 inhibitory activities:
Inhibition of COX-1 and COX-2 mediated PGE 2 production via the arachidonic acid biosynthetic cascade was determined in a 96 microwell titer plate format, as described by Fiebich et al. [23] and Reininger and Bauer [24] . Purified prostaglandin H synthase (PGHS)-1 from ram seminal vesicles and purified (PGHS)-2 from sheep placenta cotyledons were used for COX-1 and COX-2 bioassay, respectively (both enzymes from Cayman Chemical Company, Ann Arbor, USA) [25] . COX activity was measured based on the amount of PGE 2 detected by the PGE 2 EIA kit using a standard curve. Obtained values were expressed in percent at 50 µM test concentration for both enzymes. All test samples were tested in two independent observations, each time in duplicate. Results are given as mean ± SD. A dual COX-1/2 inhibitor indomethacin (ICN, Aurora, USA; IC 50 COX-1 0.9 µM) was used for COX-1 assay and selective COX-2 inhibitor NS-398 (Cayman Chemical Company; IC 50 COX-2 2.6 µM) was used for COX-2 assay, both as a positive control. The specific inhibitors were dissolved in EtOH p.a. All results were evaluated from 4 independent measurements.
HPLC and LC-ESI-MS analysis:
HPLC-DAD analysis of each extract of L. vulgare leaves and of isolated oleuropein and echinacoside was conducted on a Merck Hitachi (LaChrom, L7000 IF) liquid chromatograph equipped with a L7100 pump, L7200 autosampler, D700 interface and 125x4 mm column {Merck LiChrospher® 100, RP-18 (5µm)}. The mobile phase was composed of 0.1 % v/v H 3 PO 4 in water (A) and acetonitrile (B). A gradient solvent system was used as follows: 0-80% (A) (0 min), 80-70% (A) (25 min), 70-0% (A) (26 min), 80% (A) (35 min). The injection volume was 20 μL and the flow rate 1.0 mL.min −1 . Identification of separated compounds was performed by retention times and UV spectra recorded by a diode array detector (DAD L-7455). Analysis of each sample by LC-ESI-MS was performed using a Thermo Finnigan Surveyor liquid chromatograph connected to a LCQ TM Deca XP PLUS mass detector. Analysis of L. vulgare extracts was performed under the same conditions as identification of oleuropein and echinacoside, by a MS system equipped with electrospray ionization source (ESI) operating in the positive mode. Chromatographic separation was operated by 0.1% aqueous formic acid (eluent A) and 0.5% formic acid in acetonitrile (eluent B). The gradient system was as follows: 0-25 min 80-75% (A), 25-35 min 75-70% (A), 35-36 min 70-80% (A) and 36-45 min 80% (A). The total run time of samples (20 μL) was 30 min on a Zorbax SB-C18 analytical column (4.6x250mm). Detection wavelengths were 245, 280 and 330 nm.
